2024 Rome, Italy

I-047 Andrew Butler
Exploration of CPRD and Yellow Card real-world data to support efficacy and safety targets for levonorgestrel contraceptives.
Wednesday 10:20-11:50
I-067 Heather Collis
A case study of applying machine learning to improve non-invasive assessment of fibrosis stage in MASLD
Wednesday 10:20-11:50
I-076 Alessandro De Carlo
PopPK-PD modelling of Carboplatin-induced myelosuppression to support therapeutic drug monitoring and dose individualization in cancer patients using Electronic Health Record Data
Wednesday 10:20-11:50
II-011 Verena Gotta
Anemia control under maintenance hemodialysis (HD) and association with long-term outcome in pediatric and adolescent patients a real-world data analysis
Wednesday 15:20-16:50
II-038 Thomas Henthorn
Dose Estimation Utility in a Population Pharmacokinetic Analysis of Inhaled ?9-Tetrahydrocannabinol (THC) Cannabis Market Products in Occasional and Daily Users
Wednesday 15:20-16:50
III-006 Wen Yao Mak
Population repeated time-to-event analysis of peritonitis in end-stage renal failure: Predicting the natural progression and infection risk through nationwide registry data
Thursday 09:50-11:20
III-023 Lyndsey Meyer
Advancing Quantitative Systems Pharmacology (QSP) Disease Progression Modeling with Real-World Data: Applications for Patients with Unintentional Weight Loss
Thursday 09:50-11:20
IV-006 Valerie Sia
Aging-related CYP3A functional changes: Novel findings from a model-based assessment of real-world pharmacokinetic study in Chinese older inpatients
Thursday 15:00-16:30
IV-026 Budi Octasari Susanto
An integrative translational framework for in vitro modelling for macozinone to support prediction of early human anti-tubercular efficacy
Thursday 15:00-16:30
IV-057 Martje Van Neste
A semi-systematic review on the maturational physiology in exclusively breastfed infants: Growth A contribution from the ConcePTION project
Thursday 15:00-16:30